Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BACH1 is a transcription factor that functions primarily as a transcriptional repressor by forming heterodimers with small Maf proteins. It binds to Maf recognition elements (MAREs) in gene promoters to repress transcription of target genes such as heme oxygenase-1 (HO-1). BACH1 regulates oxidative stress response, heme homeostasis, cell cycle progression, hematopoiesis, and immunity. It is associated with breast cancer, Fanconi anemia, and metastasis. Recent studies highlight its role as a master regulator gene involved in redox biology, hypoxia response, and metastatic processes, making it an emerging therapeutic target for certain cancers.
Inhibition of BACH1 transcriptional repressor activity, modulation of BACH1-mediated gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1.